Relationship Between Estimated Glucose Disposal Rate and Type 2 Diabetic Retinopathy

References

• Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2(1):56–64. doi:10.1016/S2213-8587(13)70112-8
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Robles-Rivera RR, Castellanos-González JA, Olvera-Montaño C, et al. Adjuvant therapies in diabetic retinopathy as an early approach to delay its progression: the importance of oxidative stress and inflammation. Oxid Med Cell Longev. 2020;2020:3096470. doi:10.1155/2020/3096470
   PubMed Web of Science ®Google Scholar
• Jerneld B, Algvere P. Relationship of duration and onset of diabetes to prevalence of diabetic retinopathy. Am J Ophthalmol. 1986;102(4):431–437. doi:10.1016/0002-9394(86)90069-3
   PubMed Web of Science ®Google Scholar
• Jaross N, Ryan P, Newland H. Prevalence of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine region diabetic retinopathy study (KRDRS). Report no. 1. Clin Experiment Ophthalmol. 2003;31(1):32–39.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 10. Microvascular complications and foot care: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl1):S105–s18.
   PubMedGoogle Scholar
• Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12(4):346–354.
   PubMed Web of Science ®Google Scholar
• Kramer CK, Rodrigues TC, Canani LH, Gross JL, Azevedo MJ. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies. Diabetes Care. 2011;34(5):1238–1244.
   PubMed Web of Science ®Google Scholar
• Pearce I, Simó R, Lövestam-Adrian M, Wong DT, Evans M. Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review. Diabetes Obes Metab. 2019;21(3):467–478.
   PubMed Web of Science ®Google Scholar
• Rosenson RS, Fioretto P, Dodson PM. Does microvascular disease predict macrovascular events in type 2 diabetes? Atherosclerosis. 2011;218(1):13–18. doi:10.1016/j.atherosclerosis.2011.06.029
   PubMed Web of Science ®Google Scholar
• Gardner TW, Abcouwer SF, Barber AJ, Jackson GR. An integrated approach to diabetic retinopathy research. Arch Ophthalmol. 2011;129(2):230–235. doi:10.1001/archophthalmol.2010.362
   PubMedGoogle Scholar
• Tzeng TF, Liu WY, Liou SS, Hong TY, Liu IM. Antioxidant-rich extract from plantaginis semen ameliorates diabetic retinal injury in a streptozotocin-induced diabetic rat model. Nutrients. 2016;8:9. doi:10.3390/nu8090572
   PubMed Web of Science ®Google Scholar
• Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 2001;24(7):1275–1279. doi:10.2337/diacare.24.7.1275
   PubMed Web of Science ®Google Scholar
• Chaturvedi N, Sjoelie AK, Porta M, et al. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care. 2001;24(2):284–289. doi:10.2337/diacare.24.2.284
   PubMed Web of Science ®Google Scholar
• Parvanova A, Iliev I, Filipponi M, et al. Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes. J Clin Endocrinol Metab. 2004;89(9):4371–4376. doi:10.1210/jc.2003-032076
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214–23. doi:10.1152/ajpendo.1979.237.3.E214
   PubMed Web of Science ®Google Scholar
• Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49(4):626–632. doi:10.2337/diabetes.49.4.626
   PubMed Web of Science ®Google Scholar
• Nyström T, Holzmann MJ, Eliasson B, Svensson AM, Sartipy U. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes. Diabetes Obes Metab. 2018;20(3):556–563. doi:10.1111/dom.13110
   PubMed Web of Science ®Google Scholar
• Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh epidemiology of diabetes complication study. Kidney Int. 2002;62(3):963–970. doi:10.1046/j.1523-1755.2002.00507.x
   PubMed Web of Science ®Google Scholar
• Olson JC, Erbey JR, Forrest KY, Williams K, Becker DJ, Orchard TJ. Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes. Metabolism. 2002;51(2):248–254. doi:10.1053/meta.2002.30021
   PubMed Web of Science ®Google Scholar
• Pané A, Conget I, Boswell L, et al. Insulin resistance is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes. Diabetes Metab Res Rev. 2020;36:e3323. doi:10.1002/dmrr.3323
   PubMed Web of Science ®Google Scholar
• Orchard TJ, Olson JC, Erbey JR, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care. 2003;26(5):1374–1379. doi:10.2337/diacare.26.5.1374
   PubMed Web of Science ®Google Scholar
• Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the Diabetes Control and Complications Trial. Diabetes Care. 2007;30(3):707–712. doi:10.2337/dc06-1982
   PubMed Web of Science ®Google Scholar
• Helliwell R, Warnes H, Kietsiriroje N, et al. Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: beyond glycated haemoglobin. Diabet Med. 2021;38(5):e14529. doi:10.1111/dme.14529
   PubMed Web of Science ®Google Scholar
• Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–1682. doi:10.1016/S0161-6420(03)00475-5
   PubMed Web of Science ®Google Scholar
• Agardh E, Tababat-Khani P. Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care. 2011;34(6):1318–1319. doi:10.2337/dc10-2308
   PubMed Web of Science ®Google Scholar
• Hu Y, Teng W, Liu L, et al. Prevalence and risk factors of diabetes and diabetic retinopathy in Liaoning province, China: a population-based cross-sectional study. PLoS One. 2015;10(3):e0121477. doi:10.1371/journal.pone.0121477
   PubMed Web of Science ®Google Scholar
• Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan eye study. Ophthalmology. 2009;116(3):461–467. doi:10.1016/j.ophtha.2008.10.003
   PubMed Web of Science ®Google Scholar
• Li M, Wang Y, Liu Z, et al. Females with type 2 diabetes mellitus are prone to diabetic retinopathy: a twelve-province cross-sectional study in China. J Diabetes Res. 2020;2020:5814296. doi:10.1155/2020/5814296
   PubMedGoogle Scholar
• Chillarón JJ, Goday A, Flores-Le-Roux JA, et al. Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes. J Clin Endocrinol Metab. 2009;94(9):3530–3534. doi:10.1210/jc.2009-0960
   PubMed Web of Science ®Google Scholar
• Pop A, Clenciu D, Anghel M, et al. Insulin resistance is associated with all chronic complications in type 1 diabetes. J Diabetes. 2016;8(2):220–228. doi:10.1111/1753-0407.12283
   PubMed Web of Science ®Google Scholar
• Epstein EJ, Osman JL, Cohen HW, Rajpathak SN, Lewis O, Crandall JP. Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes. Diabetes Care. 2013;36(8):2280–2285. doi:10.2337/dc12-1693
   PubMed Web of Science ®Google Scholar
• Rowe CW, Haider AS, Viswanathan D, et al. Insulin resistance correlates with maculopathy and severity of retinopathy in young adults with Type 1 Diabetes Mellitus. Diabetes Res Clin Pract. 2017;131:154–160. doi:10.1016/j.diabres.2017.06.022
   PubMed Web of Science ®Google Scholar
• Duţă I, Fica S, Ion DA. The association between insulin resistance and proliferative retinopathy in type 1 diabetes. Rom J Intern Med. 2015;53(3):261–266. doi:10.1515/rjim-2015-0034
   PubMedGoogle Scholar
• Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt PI. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016;473(24):4527–4550. doi:10.1042/BCJ20160503C
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes. 2001;50(8):1938–1942. doi:10.2337/diabetes.50.8.1938
   PubMed Web of Science ®Google Scholar
• Koch CA, Anderson D, Moran MF, Ellis C, Pawson T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science. 1991;252(5006):668–674. doi:10.1126/science.1708916
   PubMed Web of Science ®Google Scholar
• Bai Y, Ma JX, Guo J, et al. Müller cell-derived VEGF is a significant contributor to retinal neovascularization. J Pathol. 2009;219(4):446–454. doi:10.1002/path.2611
   PubMed Web of Science ®Google Scholar
• Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, Häring HU. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016;12(12):721–737. doi:10.1038/nrneph.2016.145
   PubMed Web of Science ®Google Scholar
• Jin R, Krasinskas A, Le NA, et al. Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease. Pediatr Obes. 2018;13(1):23–29. doi:10.1111/ijpo.12183
   PubMed Web of Science ®Google Scholar
• Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011;30(5):343–358. doi:10.1016/j.preteyeres.2011.05.002
   PubMed Web of Science ®Google Scholar
• Raman R, Ganesan S, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic retinopathy in rural India. Sankara nethralaya diabetic retinopathy epidemiology and molecular genetic study III (SN-DREAMS III), report no 2. BMJ Open Diabetes Res Care. 2014;2(1):e000005. doi:10.1136/bmjdrc-2013-000005
   PubMedGoogle Scholar
• Tenconi PE, Bermúdez V, Oresti GM, Giusto NM, Salvador GA, Mateos MV. High glucose-induced phospholipase D activity in retinal pigment epithelium cells: new insights into the molecular mechanisms of diabetic retinopathy. Exp Eye Res. 2019;184:243–257. doi:10.1016/j.exer.2019.04.028
   PubMed Web of Science ®Google Scholar
• Lv P, Yu J, Xu X, Lu T, Xu F. Eriodictyol inhibits high glucose-induced oxidative stress and inflammation in retinal ganglial cells. J Cell Biochem. 2019;120(4):5644–5651. doi:10.1002/jcb.27848
   PubMed Web of Science ®Google Scholar
• Rodríguez ML, Pérez S, Mena-Mollá S, Desco MC, Ortega ÁL. Oxidative stress and microvascular alterations in diabetic retinopathy: future therapies. Oxid Med Cell Longev. 2019;2019:4940825. doi:10.1155/2019/4940825
   PubMed Web of Science ®Google Scholar
• Kumari N, Karmakar A, Ganesan SK. Targeting epigenetic modifications as a potential therapeutic option for diabetic retinopathy. J Cell Physiol. 2020;235(3):1933–1947. doi:10.1002/jcp.29180
   PubMed Web of Science ®Google Scholar
• Pollack RM, Donath MY, LeRoith D, Leibowitz G. Anti-inflammatory agents in the treatment of diabetes and its vascular complications. Diabetes Care. 2016;39(Suppl 2):S244–52. doi:10.2337/dcS15-3015
   PubMedGoogle Scholar
• Roy MS, Janal MN, Crosby J, Donnelly R. Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes. Invest Ophthalmol Vis Sci. 2013;54(8):5471–5480. doi:10.1167/iovs.13-12212
   PubMed Web of Science ®Google Scholar
• Das A, Rangasamy S, McGuire PG, Das P. Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East Afr J Ophthalmol. 2012;19(1):52–59. doi:10.4103/0974-9233.92116
   PubMedGoogle Scholar
• Shafabakhsh R, Aghadavod E, Mobini M, Heidari-Soureshjani R, Asemi Z. Association between microRNAs expression and signaling pathways of inflammatory markers in diabetic retinopathy. J Cell Physiol. 2019;234(6):7781–7787.
   PubMed Web of Science ®Google Scholar
• Dehdashtian E, Mehrzadi S, Yousefi B, et al. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Life Sci. 2018;193:20–33.
   PubMed Web of Science ®Google Scholar
• Rangasamy S, Monickaraj F, Legendre C, et al. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy. Exp Eye Res. 2020;195:108043.
   PubMed Web of Science ®Google Scholar
• Lenin R, Thomas SM, Gangaraju R. Endothelial activation and oxidative stress in neurovascular defects of the retina. Curr Pharm Des. 2018;24(40):4742–4754.
   PubMed Web of Science ®Google Scholar
• Hui Y, Yin Y. MicroRNA-145 attenuates high glucose-induced oxidative stress and inflammation in retinal endothelial cells through regulating TLR4/NF-κB signaling. Life Sci. 2018;207:212–218.
   PubMed Web of Science ®Google Scholar
• Cui RZ, Wang L, Qiao SN, et al. ON-type retinal ganglion cells are preferentially affected in STZ-Induced diabetic mice. Invest Ophthalmol Vis Sci. 2019;60(5):1644–1656.
   PubMed Web of Science ®Google Scholar
• Nadri G, Saxena S, Stefanickova J, et al. Disorganization of retinal inner layers correlates with ellipsoid zone disruption and retinal nerve fiber layer thinning in diabetic retinopathy. J Diabetes Complications. 2019;33(8):550–553.
   PubMed Web of Science ®Google Scholar
• Hao M, Li Y, Lin W, et al. Estrogen prevents high-glucose-induced damage of retinal ganglion cells via mitochondrial pathway. Graefes Arch Clin Exp Ophthalmol. 2015;253(1):83–90.
   PubMed Web of Science ®Google Scholar
• Schmidl D, Schmetterer L, Garhöfer G, Popa-Cherecheanu A. Gender differences in ocular blood flow. Curr Eye Res. 2015;40(2):201–212.
   PubMed Web of Science ®Google Scholar
• Rübsam A, Parikh S, Fort PE. Role of Inflammation in Diabetic Retinopathy. Int J Mol Sci. 2018;19:4.
   Web of Science ®Google Scholar
• Wu W, Zhou G, Han H, et al. PI3Kδ as a novel therapeutic target in pathological angiogenesis. Diabetes. 2020;69(4):736–748.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Yao T, Okumura K, Seko Y, Kitano S. Elevation of the vitreous body concentrations of oxidative stress-responsive apoptosis-inducing protein (ORAIP) in proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2019;257(7):1519–1525.
   PubMed Web of Science ®Google Scholar
• Khullar M, Cheema BS, Raut SK. Emerging evidence of epigenetic modifications in vascular complication of diabetes. Front Endocrinol. 2017;8:237.
   PubMed Web of Science ®Google Scholar
• Wan H, Wang Y, Xiang Q, et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118.
   PubMed Web of Science ®Google Scholar
• Matuszewski W, Stefanowicz-Rutkowska MM, Szychlińska M, Bandurska-Stankiewicz E. Differences in risk factors for diabetic retinopathy in type 1 and type 2 diabetes mellitus patients in north-east Poland. Medicina. 2020;56:4.
   Google Scholar
• Iwasaki T, Togashi Y, Ohshige K, et al. Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract. 2008;79(3):427–432.
   PubMed Web of Science ®Google Scholar
• Wu Z, Yu S, Kang X, et al. Association of visceral adiposity index with incident nephropathy and retinopathy: a cohort study in the diabetic population. Cardiovasc Diabetol. 2022;21(1):32.
   PubMed Web of Science ®Google Scholar
• Li X, Li HY, Yu ZW, Zhang YT, Tong XW, Gao XY. Association among lipid accumulation product, Chinese visceral obesity index and diabetic retinopathy in patients with type 2 diabetes: a cross-sectional study. Diabetes Metab Syndr Obes. 2021;14:4971–4979.
   PubMed Web of Science ®Google Scholar
• Zhou JB, Yuan J, Tang XY, et al. Is central obesity associated with diabetic retinopathy in Chinese individuals? An exploratory study. J Int Med Res. 2019;47(11):5601–5612.
   PubMed Web of Science ®Google Scholar
• Bonnet F, Ducluzeau PH, Gastaldelli A, et al. Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. Diabetes. 2011;60(6):1660–1667.
   PubMed Web of Science ®Google Scholar
• Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004;53(3):693–700.
   PubMed Web of Science ®Google Scholar
• Wang CS, Chang TT, Yao WJ, Wang ST, Chou P. Impact of increasing alanine aminotransferase levels within normal range on incident diabetes. J Formos Med Assoc. 2012;111(4):201–208.
   PubMed Web of Science ®Google Scholar